2026-527078-35-00招募中1 期
A single and multiple ascending dose study of DFL23693 in healthy volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 76
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Nieves Dias
Scientific
Dompe' Farmaceutici S.p.A.
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With ObesityElevated High-sensitivity C-reactive Protein (hsCRP)ObesityNCT07693868Novo Nordisk A/S128
已完成
1 期
Single and Multiple Ascending Dosing Administration of MF-300 in Healthy ParticipantsNCT07613684Epirium Bio Inc.100
招募中
1 期
An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study)2023-508444-22-01Region Midtjylland30
撤回
1 期
An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study)2023-508444-22-00Region Midtjylland30
招募中
1 期
Single-centre Phase I/II study with dose escalation of tocilizumab in combination with venetoclax and azacitidine chemotherapy in patients with Acute Myeloid Leukaemia (AML): TOCIVENAAcute Myeloblastic Leukemia2025-524725-41-00Centre Hospitalier Universitaire De Nantes12